This product contains recorded sessions that took place during the Academy's Annual Assembly held in San Antonio, TX from November 14-17, 2019.
The following sessions are included in this product:
Electrodiagnosis in the Inpatient Setting
Sandra L. Hearn, MD, FAAPMR (Session Director);Anthony E. Chiodo, MD, MBA, FAAPMR; Erik R. Ensrud,MD, FAAPMR; Nassim Rad, MD, FAAPMR
Challenging Electrodiagnostic Cases – MeaningfulInterpretation with Implications for Diagnosis and Referrals
Faren H. Williams, MD, MS, FAAPMR (Session Director);Erik R. Ensrud, MD, FAAPMR; Deborah A. Venesy, MD,FAAPMR
TelePM&R: Lessons Learned and the Road Ahead
Rebecca N. Tapia, MD, FAAPMR (Session Director); MarlaS. Kaufman, MD; Mary E. Matsumoto, MD, FAAPMR; JoelD. Scholten, MD
From Population Health to Autonomic Health in the Wearable Age: Decoding the Heart Brain Connection with Heart Rate Variability
Todd R. Rowland, MD, FAAPMR (Session Director); RaoufS. Gharbo, DO, FAAPMR; Gary Goldberg, MD, FAAPMR
EMG Express – Using EMG, NCV, and US to Get the Right Answer Right Away
Shawn P. Jorgensen, MD, FAAPMR (Session Director);William D. Arnold, MD, FAAPMR; Erik R. Ensrud, MD,FAAPMR
Advances in Neuromuscular Medicine and Rehabilitation Part 1 – Nerve
Colin K. Franz, MD, PhD, FAAPMR (Session Director);William D. Arnold, MD, FAAPMR; Ming Chan, MD, FRCPC;Richard L. Lieber, PhD, MBA; Gretchen A. Meyer, PhD;Sabrina Paganoni, MD, PhD, FAAPMR
Advances in Neuromuscular Medicine and Rehabilitation Part 2 – Muscle
Colin K. Franz, MD, PhD, FAAPMR (Session Director);William D. Arnold, MD, FAAPMR; Ming Chan, MD, FRCPC;Richard L. Lieber, PhD, MBA; Gretchen A. Meyer, PhD;Sabrina Paganoni, MD, PhD, FAAPMR
Physiatric Medical Missions: A Look at Traditionaland 3D-Printed Prosthetics and Orthotics in Under-Served Populations Abroad
Stephanie E. Rand, DO, FAAPMR (Session Director);Matthew N. Bartels, MD, MPH, FAAPMR; Rory A. Dixon,MBBS, DM Ortho; Lauren T. Shapiro, MD, MPH, FAAPMR;Vinay P. Vanodia, MD
Exploring the Benefits, Evidence, and Implementation of Virtual Reality for the Treatment of Acute and Chronic Pain in the Outpatient Rehabilitation Setting
David S. Binder, MD, MBA (Session Director); LornaBrown, MSPT, DPT, GCS; Zacharia Isaac, MD
Update in Cardiopulmonary Rehabilitation: New Opportunities with New Frontiers and Diagnosis
Matthew N. Bartels, MD, MPH, FAAPMR (SessionDirector); John R. Bach, MD; David Z. Prince, MD,FAAPMR; Jonathan H. Whiteson, MD, FAAPMR
Method of Study
Each session contains video presentations that were recorded during the Annual Assembly. Upon viewing the presentations, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the sessions.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
AAPM&R Medical Education Committee:
Steven R. Flanagan, MD, Chair: Royalties from Springer Publishing; research grant from Brain Injury of America.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
Justin M. Bishop, MD, MBA, MS: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Andrew B. Collins, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Nonremunerative position of influence at Cerner Corporation.
R. Sam Mayer, MD: Royalties from Demos Medical Publishing.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speakers Bureau for Allergan, Ipsen, Merz; participates in clinical trials for Ipsen, Merz, and Revance; Guideline and AUC Committee for the AAOS, nonremunerative position of influence.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
AAPM&R CME Committee:
Kerrie M. Reed, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.